• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非壶腹十二指肠癌的外科治疗:包括淋巴结清扫的根治性肿瘤切除术后长期生存良好。

Surgical treatment of non-ampullary duodenal cancer: good long term survival after radical tumour resection including lymphadenectomy.

作者信息

Schütz G, Aleksic M, Ulrich B

机构信息

Chirurgische Klinik, Kliniken der Landeshaupstadt Düsseldorf, Krankenhaus Gerresheim, Germany.

出版信息

Int J Surg Investig. 2000;1(6):525-9.

PMID:11729861
Abstract

AIMS

The aim of this study is to evaluate the role of surgery in the treatment of duodenal cancer.

METHODS

From October 1987 to January 1999, 7 patients (3 female/4 male) with primary non-ampullary duodenal adenocarcinoma underwent surgical treatment in our department. Presenting signs and symptoms were abdominal pain, weight loss, anaemia and obstruction. Upper gastrointestinal contrast study, computed tomography (CT) and duodenoscopy were the primary diagnostic procedure modalities. All diagnoses were confirmed histologically. Five of 7 patients were resectable for cure at the time of their first surgical intervention.

RESULTS

In 5 patients, the tumour could be removed with tumour-free margins. One patient, where the histopathological workup revealed tumour cells in the resection margins, died 29 months after the surgical intervention. In another patient, complete tumour resection could not be achieved. Subsequently, postoperative survival was only 2 months. Operative mortality was 0%. Patients with R0-status showed a postoperative survival of at least 24 months.

CONCLUSION

In the management of resectable non-ampullary malignancies of the duodenum, surgical radicality including lymphadenectomy should be pursued. The radical operative treatment with lymphadenectomy offers a reasonable chance for cure in some patients.

摘要

目的

本研究旨在评估手术在十二指肠癌治疗中的作用。

方法

1987年10月至1999年1月,7例原发性非壶腹十二指肠腺癌患者(3例女性/4例男性)在我科接受了手术治疗。主要症状和体征为腹痛、体重减轻、贫血和梗阻。上消化道造影、计算机断层扫描(CT)和十二指肠镜检查是主要的诊断方法。所有诊断均经组织学证实。7例患者中有5例在首次手术干预时可切除以治愈。

结果

5例患者的肿瘤可切除且切缘无肿瘤细胞。1例患者组织病理学检查显示切缘有肿瘤细胞,术后29个月死亡。另1例患者未能实现肿瘤完全切除。随后,术后生存期仅2个月。手术死亡率为0%。R0状态的患者术后生存期至少为24个月。

结论

在可切除的非壶腹十二指肠恶性肿瘤的治疗中,应追求包括淋巴结清扫在内的手术根治性。行淋巴结清扫的根治性手术治疗为部分患者提供了合理的治愈机会。

相似文献

1
Surgical treatment of non-ampullary duodenal cancer: good long term survival after radical tumour resection including lymphadenectomy.非壶腹十二指肠癌的外科治疗:包括淋巴结清扫的根治性肿瘤切除术后长期生存良好。
Int J Surg Investig. 2000;1(6):525-9.
2
Carcinoma of the duodenum: management and survival in 14 cases.十二指肠癌:14例患者的治疗与生存情况
Panminerva Med. 1997 Mar;39(1):24-9.
3
Primary nonampullary/periampullary adenocarcinoma of the duodenum.十二指肠原发性非壶腹/壶腹周围腺癌
Am Surg. 1998 Dec;64(12):1165-9.
4
Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients.十二指肠原发性腺癌:89例患者的治疗与生存情况
Hepatogastroenterology. 1997 Jul-Aug;44(16):1157-63.
5
Long-term results of radical resection for locally advanced duodenal adenocarcinoma.局部晚期十二指肠腺癌根治性切除的长期结果
Hepatogastroenterology. 2005 Nov-Dec;52(66):1727-9.
6
[Evaluation of curative and palliative treatment of duodenal adenocarcinoma].[十二指肠腺癌的根治性与姑息性治疗评估]
Ugeskr Laeger. 2010 May 3;172(18):1376-9.
7
[The role of superextended lymphadenectomy (D4) in gastric cancer].[扩大根治性淋巴结清扫术(D4)在胃癌中的作用]
Minerva Chir. 2004 Aug;59(4):325-35.
8
Surgical treatment of primary duodenal adenocarcinoma.原发性十二指肠腺癌的外科治疗
Hepatogastroenterology. 2006 Nov-Dec;53(72):858-62.
9
[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].[壶腹癌和胰腺癌的外科治疗结果及其R0切除术后的预后参数]
Zentralbl Chir. 2005 Aug;130(4):353-61. doi: 10.1055/s-2005-836794.
10
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.

引用本文的文献

1
Prognostic factors for primary duodenal adenocarcinoma.原发性十二指肠腺癌的预后因素。
World J Surg. 2008 Oct;32(10):2246-52. doi: 10.1007/s00268-008-9678-6.